ATE280779T1 - METHOD FOR PRODUCING LHRH ANTAGONISTS - Google Patents

METHOD FOR PRODUCING LHRH ANTAGONISTS

Info

Publication number
ATE280779T1
ATE280779T1 AT01978273T AT01978273T ATE280779T1 AT E280779 T1 ATE280779 T1 AT E280779T1 AT 01978273 T AT01978273 T AT 01978273T AT 01978273 T AT01978273 T AT 01978273T AT E280779 T1 ATE280779 T1 AT E280779T1
Authority
AT
Austria
Prior art keywords
producing
lhrh antagonists
lhrh
antagonists
producing lhrh
Prior art date
Application number
AT01978273T
Other languages
German (de)
Inventor
Michael Damm
Waldemar Salonek
Juergen Engel
Horst Bauer
Gabriele Stach
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27805895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE280779(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Application granted granted Critical
Publication of ATE280779T1 publication Critical patent/ATE280779T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT01978273T 2000-08-17 2001-08-09 METHOD FOR PRODUCING LHRH ANTAGONISTS ATE280779T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040700A DE10040700A1 (en) 2000-08-17 2000-08-17 Salts of biologically active peptides, their production and use
PCT/EP2001/009219 WO2002014347A2 (en) 2000-08-17 2001-08-09 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
CA002355573A CA2355573A1 (en) 2000-08-17 2001-08-22 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts

Publications (1)

Publication Number Publication Date
ATE280779T1 true ATE280779T1 (en) 2004-11-15

Family

ID=27805895

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978273T ATE280779T1 (en) 2000-08-17 2001-08-09 METHOD FOR PRODUCING LHRH ANTAGONISTS

Country Status (30)

Country Link
US (1) US6780972B2 (en)
EP (1) EP1309607B1 (en)
JP (1) JP2004506647A (en)
CN (1) CN1187369C (en)
AR (1) AR030371A1 (en)
AT (1) ATE280779T1 (en)
AU (2) AU1043902A (en)
BG (1) BG107612A (en)
BR (1) BR0113296A (en)
CA (1) CA2355573A1 (en)
CZ (1) CZ2003688A3 (en)
DE (2) DE10040700A1 (en)
DK (1) DK1309607T3 (en)
EE (1) EE200300065A (en)
ES (1) ES2230371T3 (en)
HK (1) HK1058366A1 (en)
HU (1) HUP0300738A3 (en)
IL (1) IL154150A0 (en)
MX (1) MXPA03001448A (en)
NO (1) NO20030618D0 (en)
NZ (1) NZ524023A (en)
PL (1) PL204496B1 (en)
PT (1) PT1309607E (en)
RU (1) RU2266296C2 (en)
SI (1) SI1309607T1 (en)
SK (1) SK3032003A3 (en)
TW (1) TWI236910B (en)
UA (1) UA74005C2 (en)
WO (1) WO2002014347A2 (en)
ZA (1) ZA200300777B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (en) * 2004-12-22 2006-06-28 Zentaris GmbH Process for the manufacture of sterile suspensions or lyophilisates of low-soluble basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament
RU2525661C2 (en) * 2012-11-15 2014-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) Method of obtaining high-titre antimicrobial serum for estimation of antigen activity of anti-staphylococcal vaccines
CN107056894B (en) * 2017-05-26 2021-07-20 济南康和医药科技有限公司 Method for solid-phase synthesis of ganirelix acetate by fragment method
EP3590526A1 (en) * 2018-07-05 2020-01-08 Antev Limited A lyophilization process and a teverelix-tfa lyophilizate obtained thereby
CN114249800A (en) * 2020-09-22 2022-03-29 深圳市星银医药有限公司 Preparation method of pamoic acid polypeptide drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431635A (en) * 1979-06-13 1984-02-14 Coy David Howard LH-RH Antagonists
DE3165535D1 (en) * 1980-06-02 1984-09-20 Andrew Victor Schally Lh-rh antagonists
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
DE4305225A1 (en) * 1993-02-19 1994-08-25 Asta Medica Ag New manufacturing process for Cetrorelix lyophilisate
EP0626170A3 (en) * 1993-05-10 1996-03-27 Sandoz Ltd Stabilisation of pharmacologically active compounds in sustained release compositions.
DE4342092B4 (en) * 1993-12-09 2007-01-11 Zentaris Gmbh Long-acting suspension for injection and method of preparation
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
RU2230550C2 (en) * 1998-01-16 2004-06-20 Такеда Кемикал Индастриз, Лтд. Sustained-release compositions, method for their preparing and application

Also Published As

Publication number Publication date
ZA200300777B (en) 2003-09-18
SI1309607T1 (en) 2005-02-28
TWI236910B (en) 2005-08-01
RU2266296C2 (en) 2005-12-20
HUP0300738A2 (en) 2003-09-29
PL359495A1 (en) 2004-08-23
EE200300065A (en) 2004-12-15
IL154150A0 (en) 2003-07-31
PL204496B1 (en) 2010-01-29
AU2002210439B2 (en) 2005-10-20
BG107612A (en) 2003-12-31
HK1058366A1 (en) 2004-05-14
CN1187369C (en) 2005-02-02
AU1043902A (en) 2002-02-25
MXPA03001448A (en) 2004-12-13
AR030371A1 (en) 2003-08-20
UA74005C2 (en) 2005-10-17
DK1309607T3 (en) 2005-01-17
WO2002014347A3 (en) 2002-08-08
PT1309607E (en) 2005-02-28
US20020198146A1 (en) 2002-12-26
JP2004506647A (en) 2004-03-04
ES2230371T3 (en) 2005-05-01
HUP0300738A3 (en) 2004-08-30
CZ2003688A3 (en) 2004-03-17
NO20030618L (en) 2003-02-07
RU2003107560A (en) 2005-01-27
DE10040700A1 (en) 2002-02-28
WO2002014347A2 (en) 2002-02-21
EP1309607A2 (en) 2003-05-14
NO20030618D0 (en) 2003-02-07
EP1309607B1 (en) 2004-10-27
CN1447817A (en) 2003-10-08
US6780972B2 (en) 2004-08-24
SK3032003A3 (en) 2004-05-04
NZ524023A (en) 2004-11-26
CA2355573A1 (en) 2003-02-22
DE50104316D1 (en) 2004-12-02
BR0113296A (en) 2003-07-15

Similar Documents

Publication Publication Date Title
ATE386736T1 (en) METHOD FOR PRODUCING BENZIMIDAZOLE-2-YL - QUINOLINONE DERIVATIVES
DE60107450D1 (en) METHOD FOR PRODUCING FLUOROELASTOMERS
DE60221399D1 (en) METHOD FOR PRODUCING MEDIUM-DISTILLATES
AT7110U9 (en) METHOD FOR PRODUCING AMLODIPINMALEATE
ATE403641T1 (en) METHOD FOR PRODUCING O-DESMETHYLVENLAFAXIN
DE60133118D1 (en) METHOD FOR PRODUCING SURFACE ELEMENTS
DE60126336D1 (en) METHOD FOR PRODUCING HIGH-PURGING PERCUSSIONAL PERIPHERAL OBJECTS
ATE328885T1 (en) METHOD FOR PRODUCING SULFONAMIDE-SUBSTITUTED IMIDAZOTRIAZINONES
DE50102444D1 (en) METHOD FOR PRODUCING ISOCYANATOORGANOSILANES
ATE316518T1 (en) METHOD FOR PRODUCING (R)-2-ALKYL-3-PHENYL-1-PROPANOLS
DE50111560D1 (en) METHOD FOR PRODUCING GUERBETALCOCOOLS
DE60003264D1 (en) METHOD FOR PRODUCING GLYCERYLETHERS
ATE266004T1 (en) METHOD FOR PRODUCING 3-AMINO-2-CHLORINE-4-METHYLPYRIDINE
ATE272626T1 (en) METHOD FOR PRODUCING PYRAZOLOPYRIMIDINONES
DE50006772D1 (en) METHOD FOR PRODUCING OXINDOLS
DE50200870D1 (en) METHOD FOR PRODUCING HYDROXYALKYLPOLYSILOXANES
DE60105991D1 (en) METHOD FOR PRODUCING 6-AMINOCAPRONAMIDE
DE50104316D1 (en) METHOD FOR PRODUCING LHRH ANTAGONISTS
ATE296850T1 (en) METHOD FOR PRODUCING POLYAMIDES
DE60134415D1 (en) METHOD FOR PRODUCING WASH-WEAKMAKER COMPOSITIONS
DE50001895D1 (en) METHOD FOR PRODUCING PHOSPHONOMETHYLGLYCIN
ATE232845T1 (en) METHOD FOR PRODUCING CYCLOPROPENES
DE50112792D1 (en) METHOD FOR PRODUCING CAPACITOR STRUCTURES
ATE325810T1 (en) METHOD FOR PRODUCING ACETYLAMIDINIOPHENYLALANYL-CYCLOHEXYLGLYCYL-PYRIDYLALANINAMIDES
ATE233238T1 (en) METHOD FOR PRODUCING 3-ACYL-INDOLENE

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee